Single-institution experience with 18F-DOPA and 68Ga-DOTA-TOC as a PET imaging tracer for peptide receptor radionuclide therapy in well-differentiated neuroendocrine neoplasms

W. Noordzij*

*Corresponding author for this work

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)199-199
Number of pages1
JournalJournal of Neuroendocrinology
Publication statusPublished - Feb-2021
Event18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease -
Duration: 25-Feb-202127-Feb-2021


  • neuroendocrine tumor
  • pet tracer
  • 18f-dopa
  • 68ga-dota-toc
  • carbidopa
  • peptide receptor radionuclide therapy
  • prrt

Cite this